Desimone Colleen Elizabeth - Net Worth and Insider Trading
Desimone Colleen Elizabeth Net Worth
The estimated net worth of Desimone Colleen Elizabeth is at least $0 dollars as of 2024-11-13. Desimone Colleen Elizabeth is the Principal Accounting Officer of Syros Pharmaceuticals Inc and owns about 0 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $0. Details can be seen in Desimone Colleen Elizabeth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Desimone Colleen Elizabeth has not made any transactions after 2017-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Desimone Colleen Elizabeth
Desimone Colleen Elizabeth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Desimone Colleen Elizabeth owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Desimone Colleen Elizabeth’s form 4 insider trades.
Insider Ownership Summary of Desimone Colleen Elizabeth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2017-10-23 | Principal Accounting Officer |
Desimone Colleen Elizabeth Latest Holdings Summary
Desimone Colleen Elizabeth currently owns a total of 1 stock. Desimone Colleen Elizabeth owns 0 shares of Syros Pharmaceuticals Inc (SYRS) as of October 23, 2017, with a value of $0.
Latest Holdings of Desimone Colleen Elizabeth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2017-10-23 | 0 | 2.73 | 0 |
Holding Weightings of Desimone Colleen Elizabeth
Desimone Colleen Elizabeth Form 4 Trading Tracker
According to the SEC Form 4 filings, Desimone Colleen Elizabeth has made a total of 0 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 55 shares on October 23, 2017, which brought Desimone Colleen Elizabeth around $8,833.
Insider Trading History of Desimone Colleen Elizabeth
- 1
Desimone Colleen Elizabeth Trading Performance
Desimone Colleen Elizabeth Ownership Network
Ownership Network List of Desimone Colleen Elizabeth
Ownership Network Relation of Desimone Colleen Elizabeth
Desimone Colleen Elizabeth Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Desimone Colleen Elizabeth is the Principal Accounting Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Desimone Colleen Elizabeth made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Desimone Colleen Elizabeth Mailing Address
Above is the net worth, insider trading, and ownership report for Desimone Colleen Elizabeth. You might contact Desimone Colleen Elizabeth via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive, Suite 300, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
